Center Laboratories, Inc. (TPEX:4123)
31.70
-0.15 (-0.47%)
Aug 28, 2026, 1:30 PM CST
Center Laboratories Market Cap
Center Laboratories has a market cap or net worth of 25.19 billion as of August 28, 2026. Its market cap has decreased by -4.94% in one year.
Market Cap
25.19B
Enterprise Value
25.69B
Revenue
1.66B
Ranking
n/a
PE Ratio
25.06
Stock Price
31.70
ChartMarket Cap Chart
Since November 3, 2004, Center Laboratories's market cap has increased from 358.01M to 25.19B, an increase of 6,937.12%. That is a compound annual growth rate of 21.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 25.19B | -18.88% |
| Dec 31, 2025 | 31.06B | -1.69% |
| Dec 31, 2024 | 31.59B | 3.14% |
| Dec 29, 2023 | 30.63B | 8.88% |
| Dec 30, 2022 | 28.13B | -7.93% |
| Dec 30, 2021 | 30.56B | -3.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bora Pharmaceuticals | 59.86B |
| Lotus Pharmaceutical | 51.65B |
| TTY Biopharm Company | 19.34B |
| Synmosa Biopharma | 16.14B |
| ScinoPharm Taiwan | 15.02B |
| YungShin Global Holding | 14.81B |
| Grape King Bio | 13.35B |
| Foresee Pharmaceuticals | 12.51B |